Rebecca Little is the Executive Vice President Clinical Strategy and Development at Objective Health.

In this episode, we discuss changes in the industry. We address the need to integrate research into the flow of patient care and forge collaborative relationships through education and communication.

We explore patient education about clinical trials and the need for communication and education of patients and the impact on retention in clinical trials.

We discuss the role of advocacy groups in engaging communities and using real data for site feasibility. We chat about integrating technology into the workflow and tips for ensuring compliance.

We touch on turn-over at both the site and CRA level and and the role of education and communication.

We explore campaigns and strategies to meaningfully move the needle for patients.

Have a listen and let us know what most resonates.

Rebecca Little is an Executive Vice President, Clinical Strategy and Development at ObjectiveHealth. Prior to joining ObjectiveHealth, Rebecca led the global commercial team for ICON’s clinical research site network, where Rebecca specialized in developing and growing partnerships with both large pharma and biotechs, specifically in the therapeutic areas of Immuno-Inflammation (GI and Derm), Respiratory, CNS, Vaccines, Women’s Health and CVM. Rebecca has worked in the clinical research industry for the last 16 years, both in the research site networks and full service CRO spaces. Rebecca graduated from Clemson University with a BS in Health Science.